Back to Blog
M&A Strategy11 min read

Who's Buying Home Care Agencies in 2026? The Complete Buyer Landscape

From PE platform builders to public strategics like Addus and Pennant, here's who is actively acquiring home care agencies and what each buyer type means for your deal.

BB
Billy BaumannFounder, Exit Lab | Home Care
February 6, 2026

Understanding who is buying home care agencies, and why, is one of the most important factors in planning a successful exit. The buyer you ultimately sell to will determine not just your sale price, but also the deal structure, the transition period, what happens to your employees, and your own post-sale obligations. In 2025, Capstone Partners documented 104 transactions across the home care sector. Analyzing who completed those deals reveals a buyer landscape that is more diverse, more competitive, and more sophisticated than at any point in the sector's history. Use our exit timeline calculator to plan your approach to these buyer categories. Learn how to evaluate their offers.

Why This Matters for Your Sale

Different buyer types value different things. A PE firm building a platform cares about scalability and management infrastructure. A strategic acquirer cares about geographic overlap and payer contracts. A local competitor cares about your referral relationships and staff. Knowing who your likely buyers are before you go to market allows you to position your agency to maximize its appeal and your sale price.

The Four Buyer Categories

Home care acquisitions in 2025 fell into four distinct buyer categories, each with different motivations, valuation approaches, and deal structures. Strategic buyers completed 61 transactions (58.7% of total activity), while private equity-backed buyers completed 43 deals (41.3%). Within those broad categories, the dynamics vary significantly.

1. Public Strategic Acquirers

Public companies were dramatically more active in 2025, completing 20 transactions compared to just 7 in 2024. These are the largest buyers in the market, with the financial resources to pay premium multiples for the right assets. Key public acquirers active in the home care space include:

CompanyFocusStrategyWhat They Look For
Addus HomeCarePersonal care, home health, hospiceGeographic expansion, service line growthMedicaid waiver programs, managed care contracts
The Pennant GroupHome health, hospiceDecentralized operating model, tuck-insStrong local leadership, clinical outcomes
Amedisys / OptumHome health, hospiceIntegration with UnitedHealth ecosystemValue-based care capabilities, MA alignment
Enhabit Home Health & HospiceHome health, hospiceOperational optimization, selective growthEfficient operations, strong referral networks

Public strategics typically pay the highest multiples because they can realize the most synergies from an acquisition. They already have corporate infrastructure, compliance programs, technology platforms, and payer contracts that can be extended to acquired agencies. The Optum-Amedisys combination, which closed in 2025 after a two-year regulatory review at a reported $3.3 billion valuation, illustrates the scale at which public strategics operate.

2. Private Company Strategic Buyers

Private strategic buyers accounted for 67.2% of all strategic transaction volume in 2025. These are typically regional operators with 3-10 locations looking to expand into adjacent markets or add complementary service lines. They may be backed by private equity or family-owned, but their acquisition strategy is driven by operational synergies rather than financial engineering.

Selling to a private strategic buyer often means a smoother cultural transition for your staff and patients. These buyers understand the local market dynamics, have existing relationships with referral sources, and typically plan to keep the acquired agency's operations largely intact. However, they may not be able to pay as high a multiple as public strategics or well-capitalized PE firms, and their due diligence process can be less structured.

3. Private Equity Platform Builders

The most dramatic growth in buyer activity came from PE firms establishing new platforms. According to Capstone Partners, 11 new platform investments were made in 2025, an 83.3% increase over 2024. Each platform investment represents a PE firm's initial entry into the home care sector, typically involving a larger, well-managed agency that will serve as the foundation for a roll-up strategy.

If your agency is selected as a platform investment, you can expect a premium valuation, typically 6x-10x EBITDA depending on size and quality. The PE firm will bring capital for growth, professional management resources, and a clear plan to build scale through add-on acquisitions. The trade-off is that PE buyers typically require the owner to stay involved for a transition period (often 1-3 years) and may structure a significant portion of the purchase price as an earnout tied to future performance.

For a deeper understanding of how PE firms evaluate and structure deals, see our comprehensive guide on Private Equity in Home Care.

4. PE-Backed Add-On Acquirers

The largest category of PE-related activity was add-on acquisitions, with 32 deals completed in 2025 (up 45.5% YOY). These are acquisitions made by existing PE-backed platforms looking to add geographic coverage, service capabilities, or patient volume. Add-on acquisitions typically command lower multiples than platform deals (3x-6x EBITDA for smaller agencies) because the buyer already has the infrastructure and is primarily acquiring revenue and relationships.

However, add-on deals can still be attractive for sellers. The process is often faster because the buyer has a proven integration playbook, and the combined entity may offer better career opportunities for your staff. If your agency is in a market where a PE-backed platform is actively building, you may find yourself in a competitive situation with multiple interested buyers.

What Each Buyer Type Pays

Buyer TypeTypical MultipleDeal SpeedEarnout LikelihoodTransition Period
Public Strategic6x – 12x+ EBITDA4-8 monthsLow-Medium6-12 months
Private Strategic4x – 8x EBITDA3-6 monthsMedium3-12 months
PE Platform6x – 10x EBITDA4-8 monthsHigh1-3 years
PE Add-On3x – 6x EBITDA2-4 monthsMedium-High6-18 months

Ranges based on industry transaction data and advisory experience. Actual multiples vary based on agency size, quality, and market conditions. See our detailed valuation multiples guide for more specifics.

What Buyers Are Prioritizing in 2026

Across all buyer types, several themes consistently emerged in 2025 deal activity and are expected to intensify in 2026. According to PwC's Health Services Deals Outlook, buyers are increasingly focused on technology-enabled operations, value-based care capabilities, and scalable platforms.

Compliance infrastructure. With regulatory scrutiny increasing, particularly in hospice and in states with enhanced oversight programs, buyers are placing a premium on agencies with documented compliance programs, clean survey histories, and audit-ready operations. A compliance deficiency discovered during due diligence can reduce your valuation by 1x-2x EBITDA or kill a deal entirely.

Technology and data capabilities. Buyers want agencies that can demonstrate outcomes through data. This means robust EMR systems, outcome tracking, and the ability to share clinical data with referral partners and payers. The launch of the TEAM model in January 2026 has made this even more important for home health agencies.

Diversified payer mix. Agencies dependent on a single payer source, whether Medicare fee-for-service, a single Medicaid waiver program, or one large managed care contract, carry concentration risk that buyers will discount. The most attractive agencies have revenue spread across Medicare, Medicaid, Medicare Advantage, private pay, and multiple managed care contracts.

Management depth. Buyers consistently cite owner dependency as a key risk factor. Agencies with strong middle management, documented processes, and the ability to operate without the owner's daily involvement command premium valuations. This is especially important for PE buyers who need the business to continue performing through the transition period.

Caregiver retention. In a labor market where caregiver turnover remains a persistent challenge, agencies that have solved the retention puzzle are highly valued. Buyers look at turnover rates, average tenure, recruitment costs, and the systems in place to attract and retain quality caregivers. Strong retention metrics signal operational excellence and reduce integration risk.

How to Position Your Agency for the Right Buyer

The buyer landscape analysis suggests several strategic actions for agency owners planning an exit:

Know your likely buyer profile. A $2M revenue single-location agency is unlikely to attract a public strategic buyer. Your most likely buyers are private strategics in your market and PE-backed platforms looking for add-ons. Conversely, a $15M multi-location agency with strong management and diversified payers could attract interest from all four buyer categories. Understanding your likely buyer profile helps you focus your preparation efforts.

Build what buyers want before you go to market. The 12-18 months before a sale is your opportunity to address the factors that buyers prioritize. Our guide on preparing your agency for sale provides a detailed roadmap, but the highest-impact actions are cleaning your financials, strengthening your management team, and ensuring compliance readiness.

Create competitive tension. The best outcomes for sellers occur when multiple qualified buyers are competing for the agency. With 11 new PE platforms and 20 active public strategics, the conditions for competitive processes are strong. An experienced advisor can help you identify and approach the right universe of buyers to maximize competitive tension and your ultimate sale price.

Find Out Who Would Buy Your Agency

Your agency's size, type, geography, and financial profile determine which buyers are most likely to be interested. Get a confidential assessment that includes buyer profile analysis and valuation estimate.

Found this helpful? Share it with other home care owners.

BB

Billy Baumann

Founder, Exit Lab | Home Care

Billy Baumann is the founder of Exit Lab and a principal at Second Chair Advisory LLC. He helps home care and home health agency owners understand their valuation, prepare for exit, and navigate the M&A process with confidence. His work combines real transaction data with practical guidance built for operators, not Wall Street.

Where Does Your Agency Stand?

Get your personalized valuation range and exit readiness score in under 5 minutes. Free, confidential, no obligation.

Ready to Know Where You Stand?

Get your personalized valuation estimate and exit readiness score in about 5 minutes. No obligation, no pressure.